Thus, the main objective of the present study was to ascertain whether ANGPTL-4 levels are altered in children with obesity and determine a possible role of this protein in the BMI reduction achieved after obesity-oriented procedures in pediatric patients, suitable to be used as a potential biomarker for the risk of obesity in children. The gene discussed is ANGPTL4; the disease is obesity disorder.